Surgical debulking of gastrointestinal stromal tumors: Is it a reasonable option after second-line treatment with sunitinib?
- 17 January 2008
- journal article
- case report
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 134 (5) , 625-630
Abstract
After imatinib treatment, the surgical management of patients affected by gastrointestinal stromal tumor (GIST) has been widely reported and often considered by many oncologists in clinical practice. Surgical results are correlated with disease responsiveness to tyrosine kinase inhibitors and with complete extirpation of all tumor sites. By now, no report specifically addressing surgical management after second-line treatment with sunitinib is still available. Most patients have an unresectable disease and do not have any other therapeutical options except for clinical trials.Keywords
This publication has 24 references indexed in Scilit:
- Disease Progression Following Imatinib Failure in Gastrointestinal Stromal Tumors: Role of Surgical TherapyThe Oncologist, 2007
- Surgery of Residual Disease Following Molecular-targeted Therapy With Imatinib Mesylate in Advanced/Metastatic GISTAnnals of Surgery, 2007
- Results of Tyrosine Kinase Inhibitor Therapy Followed by Surgical Resection for Metastatic Gastrointestinal Stromal TumorAnnals of Surgery, 2007
- Gastrointestinal Stromal Tumors With KIT Exon 11 Deletions Are Associated With Poor PrognosisGastroenterology, 2006
- Management of Gastrointestinal Stromal Tumors in the Imatinib Era: Selected Case StudiesThe Oncologist, 2006
- Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate eraCancer, 2005
- Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trialThe Lancet, 2004
- DiscussionSurgery, 2003
- Surgical treatment of gastrointestinal stromal tumors in the imatinib (STI-571) eraSurgery, 2003
- Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal TumorsNew England Journal of Medicine, 2002